与此同时,美国癌症学会估计2024年美国将有大约66440人将被诊断为...查看全文
时间的p友2022-11-10 22:00
语言力求简洁。
这两天有两款PDAC的药消息说出来了,说是有breakthrough了?就详细的去看了看,话不多说,直接甩干货。
1.pelareorep
1.1 公司底色
公司:Oncolytics。机制上面大概是这个意思:意思是说有种溶瘤病毒,可以特异性的感染癌细胞,在正常细胞里面会被清理掉,引发免疫...查看全文
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-31 AccNo: 0001129928-19-000066 Size: 352 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-22 AccNo: 0001129928-19-000064 Size: 366 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-17 AccNo: 0001129928-19-000062 Size: 350 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-15 AccNo: 0001129928-19-000060 Size: 352 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-30 AccNo: 0001129928-19-000058 Size: 346 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-23 AccNo: 0001129928-19-000056 Size: 349 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-14 AccNo: 0001129928-19-000052 Size: 353 KB 网页链接
$溶瘤生物科技(ONCY)$ SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] Filed: 2019-08-14 AccNo: 0001144204-19-040143 Size: 950 KB 网页链接
$溶瘤生物科技(ONCY)$ SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] Filed: 2019-08-16 AccNo: 0001144204-19-040329 Size: 820 KB 网页链接
$溶瘤生物科技(ONCY)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-16 AccNo: 0001144204-19-040344 Size: 334 KB 网页链接